Related Experiment Video
Updated: Aug 5, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
Low dose interferon-alpha therapy for HIV-associated multicentric Castleman's disease
1Section of Infectious Diseases, Department of Medicine, St Vincent's Hospital and Medical Center, New York, NY, USA. JillANord@AOL.COM
Weekly interferon-alpha provides successful maintenance therapy for patients with HIV-associated multicentric Castleman
Area of Science:
- Oncology
- Immunology
- Infectious Diseases
Background:
- HIV-associated multicentric Castleman's disease (MCD) is a rare lymphoproliferative disorder.
- It is often associated with significant morbidity and mortality.
Observation:
- This study describes a case of successful maintenance therapy for HIV-MCD.
- The therapy utilized weekly interferon-alpha.
Findings:
- Weekly interferon-alpha demonstrated efficacy in maintaining remission for HIV-MCD.
- This treatment approach offers a viable option for long-term disease management.
Implications:
- Interferon-alpha can be an effective maintenance therapy for HIV-MCD.
- This finding may guide future treatment strategies for this rare condition.
Related Concept Videos
Retrovirus Life Cycles
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Cryptococcal Meningitis
Inhibitors of Viral Protein Synthesis

